PhRMA brings scientists to Capitol Hill

WASHINGTON — The Pharmaceutical Research and Manufacturers of America (PhRMA) on Wednesday brought 60 of its member companies’ researchers to Capitol Hill for meetings with members of Congress. The researchers will discuss with lawmakers how they can support developing new, innovative medicines. 

 

“America's biopharmaceutical researchers and scientists are on the frontlines of cutting-edge science bringing new treatments and cures to patients,” PhRMA president and CEO Stephen J. Ubl said. “I'm excited that our companies will be visiting with members of Congress to share why it's critical to support pro-innovation policies that continue to allow America to be the leader in biopharmaceutical innovation around the globe.”

 

PhRMA said researchers will also discuss the strides made in recent years by the biopharmaceutical industry, among them innovative hepatitis C medicines and more than 500 medicines developed to treat rare diseases that affect 25 million Americans.